Votumumab (KS Biomedix Limited)

N/A

Report date: 2025/09/05 17:53:37

Base Information

Drug NameVotumumab (KS Biomedix Limited)
Drug Alias NameTc 99m votumumab伏妥莫单抗HumaSPECT
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody diagnosticsBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanRadiation-emitting products > Radioactive therapeutic agent +[6] 
Mechanisms of ActionRadionuclide imaging enhancers
TargetsNot applicable
Therapy Area/IndicationsColorectal Neoplasms
Global Approved IndicationsColorectal Neoplasms
Approved Indications in ChinaN/A
Original Approved Country/TerritoryEU
Original Approved Date1998/09/25
Country/TerritoryEU
CombinationsNo
Global Highest StatusWithdrawn
Highest Status in ChinaN/A
Originator CompaniesXenova
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesXenova Biomedix Ltd
Active IndicationsN/A
Inactive IndicationsColorectal Neoplasms

Other Information

ATC CodeV09IX
Related LinksWikipediaKEGG